Exir Nano Sina

Exir Nano Sina is a leading Iranian knowledge-based biotechnology company that focuses on the development and commercialization of advanced nanomedicines. The company utilizes proprietary nanoliposome and nanomicelle delivery technologies to optimize the pharmacokinetic profiles and reduce the side effects of established therapeutic agents. Its flagship products include SinaDoxosome, a liposomal doxorubicin used in oncology, and SinaAmpholeish, a topical liposomal formulation for the treatment of cutaneous leishmaniasis. Additionally, the company produces SinaCurcumin, a high-bioavailability nanomicellar formulation of curcumin for inflammatory conditions. Exir Nano Sina operates GMP-certified manufacturing facilities and is a prominent player in the Middle Eastern nanotechnology sector, bridging the gap between academic research and clinical application.